Technical Analysis for AMAM - Ambrx Biopharma Inc.

Grade Last Price % Change Price Change
F 8.5 -0.47% -0.04
AMAM closed up 5.3 percent on Tuesday, December 7, 2021, on 69 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical AMAM trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish -0.47%
NR7 Range Contraction -0.47%
Lower Bollinger Band Walk Weakness -0.47%
Inside Day Range Contraction -0.47%
Wide Bands Range Expansion -0.47%
Lower Bollinger Band Touch Weakness -0.47%
Oversold Stochastic Weakness -0.47%
New 52 Week Closing Low Bearish 4.81%
Lower Bollinger Band Walk Weakness 4.81%
New 52 Week Low Weakness 4.81%
Older End-of-Day Signals for AMAM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 20 hours ago
Possible Inside Day about 20 hours ago
60 Minute Opening Range Breakout about 23 hours ago
Up 5% about 23 hours ago
Up 3% about 23 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. These include next generation antibody drug conjugates (ADCs), bispecifics, targeted immuno-oncology therapies, novel cytokines to modulate the immune system, and long-acting therapeutic peptides for metabolic and cardiovascular disease. Ambrx is advancing a robust portfolio of clinical and preclinical programs designed to optimize efficacy, safety and ease of use, in multiple therapeutic areas, including its lead product candidate ARX788. In addition, the company has clinical collaborations with Bristol Myers Squibb, Astellas, BeiGene, Sino Biopharma, Elanco and NovoCodex, for drug candidates generated using Ambrx technology.

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Immunology Health Sciences Pharmacy Cancer Immunotherapy Sutro Biopharma Oncology Therapies Antibody Drug Conjugate

Is AMAM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 22.8702
52 Week Low 7.82
Average Volume 11,040
200-Day Moving Average 0.00
50-Day Moving Average 11.99
20-Day Moving Average 10.78
10-Day Moving Average 9.60
Average True Range 1.00
ADX 22.94
+DI 11.95
-DI 29.76
Chandelier Exit (Long, 3 ATRs) 10.44
Chandelier Exit (Short, 3 ATRs) 10.82
Upper Bollinger Bands 13.55
Lower Bollinger Band 8.01
Percent B (%b) 0.09
BandWidth 51.34
MACD Line -1.07
MACD Signal Line -0.84
MACD Histogram -0.2304
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.59
Resistance 3 (R3) 9.53 9.11 9.42
Resistance 2 (R2) 9.11 8.85 9.15 9.36
Resistance 1 (R1) 8.83 8.68 8.97 8.89 9.30
Pivot Point 8.41 8.41 8.49 8.45 8.41
Support 1 (S1) 8.13 8.15 8.27 8.19 7.78
Support 2 (S2) 7.71 7.98 7.75 7.72
Support 3 (S3) 7.43 7.71 7.67
Support 4 (S4) 7.49